Clinical Trial Update: Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the effect of empagliflozin versus placebo on brain insulin sensitivity in adults with prediabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: PreDiabetes, Body Weight | Phase 2 | Status: COMPLETED